Caprospinol

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCaprospinol
Drug Alias NameSP-04-SamaritanSP-08SP-233SP-04mSP-004 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitorsIslet amyloid polypeptide inhibitorsSigma opioid receptor antagonists
TargetsSigma opioid receptorIslet amyloid polypeptideAcetylcholinesterase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSamaritan Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSamaritan LlcAdvinus
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksDrugBank